vs
Ceribell, Inc.(CBLL)与CuriosityStream Inc.(CURI)财务数据对比。点击上方公司名可切换其他公司
Ceribell, Inc.的季度营收约是CuriosityStream Inc.的1.3倍($24.8M vs $19.2M),CuriosityStream Inc.净利率更高(-19.7% vs -54.6%,领先34.9%),CuriosityStream Inc.自由现金流更多($3.9M vs $-11.0M)
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业,主打便携式快速脑电图检测设备,可为急症、重症护理场景提供便捷的癫痫发作监测解决方案,核心市场覆盖北美地区,目前正逐步推进全球化业务布局。
CuriosityStream是来自美国的流媒体订阅点播服务商,主打纪实类影视内容,涵盖纪录片长片、系列纪实节目与电视栏目。除了品牌同名的视频点播订阅服务外,该公司还开设了Curiosity纪实线性电视频道,目前已接入FuboTV、Roku频道等多个平台。
CBLL vs CURI — 直观对比
营收规模更大
CBLL
是对方的1.3倍
$19.2M
净利率更高
CURI
高出34.9%
-54.6%
自由现金流更多
CURI
多$14.9M
$-11.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $24.8M | $19.2M |
| 净利润 | $-13.5M | $-3.8M |
| 毛利率 | 87.3% | — |
| 营业利润率 | -58.9% | -17.6% |
| 净利率 | -54.6% | -19.7% |
| 营收同比 | — | 35.8% |
| 净利润同比 | — | -34.6% |
| 每股收益(稀释后) | $-0.35 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CBLL
CURI
| Q4 25 | $24.8M | $19.2M | ||
| Q3 25 | $22.6M | $18.4M | ||
| Q2 25 | $21.2M | $19.0M | ||
| Q1 25 | $20.5M | $15.1M | ||
| Q4 24 | — | $14.1M | ||
| Q3 24 | $17.2M | $12.6M | ||
| Q2 24 | — | $12.4M | ||
| Q1 24 | — | $12.0M |
净利润
CBLL
CURI
| Q4 25 | $-13.5M | $-3.8M | ||
| Q3 25 | $-13.5M | $-3.7M | ||
| Q2 25 | $-13.6M | $784.0K | ||
| Q1 25 | $-12.8M | $319.0K | ||
| Q4 24 | — | $-2.8M | ||
| Q3 24 | $-10.4M | $-3.1M | ||
| Q2 24 | — | $-2.0M | ||
| Q1 24 | — | $-5.0M |
毛利率
CBLL
CURI
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率
CBLL
CURI
| Q4 25 | -58.9% | -17.6% | ||
| Q3 25 | -64.8% | -24.5% | ||
| Q2 25 | -70.5% | 2.5% | ||
| Q1 25 | -69.3% | 0.5% | ||
| Q4 24 | — | -27.4% | ||
| Q3 24 | -57.8% | -25.8% | ||
| Q2 24 | — | -20.6% | ||
| Q1 24 | — | -30.4% |
净利率
CBLL
CURI
| Q4 25 | -54.6% | -19.7% | ||
| Q3 25 | -59.6% | -20.4% | ||
| Q2 25 | -64.4% | 4.1% | ||
| Q1 25 | -62.4% | 2.1% | ||
| Q4 24 | — | -19.9% | ||
| Q3 24 | -60.6% | -24.3% | ||
| Q2 24 | — | -16.4% | ||
| Q1 24 | — | -42.0% |
每股收益(稀释后)
CBLL
CURI
| Q4 25 | $-0.35 | $-0.07 | ||
| Q3 25 | $-0.37 | $-0.06 | ||
| Q2 25 | $-0.38 | $0.01 | ||
| Q1 25 | $-0.36 | $0.01 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | $-1.85 | $-0.06 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $159.3M | $27.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $155.3M | $41.5M |
| 总资产 | $195.8M | $75.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CBLL
CURI
| Q4 25 | $159.3M | $27.3M | ||
| Q3 25 | $168.5M | $27.8M | ||
| Q2 25 | $177.4M | $28.1M | ||
| Q1 25 | $182.7M | $33.4M | ||
| Q4 24 | — | $32.1M | ||
| Q3 24 | $14.1M | $33.2M | ||
| Q2 24 | — | $39.5M | ||
| Q1 24 | — | $38.8M |
股东权益
CBLL
CURI
| Q4 25 | $155.3M | $41.5M | ||
| Q3 25 | $164.1M | $47.2M | ||
| Q2 25 | $172.2M | $49.8M | ||
| Q1 25 | $180.9M | $58.1M | ||
| Q4 24 | — | $57.8M | ||
| Q3 24 | $-136.0M | $62.2M | ||
| Q2 24 | — | $64.8M | ||
| Q1 24 | — | $67.0M |
总资产
CBLL
CURI
| Q4 25 | $195.8M | $75.7M | ||
| Q3 25 | $199.5M | $74.7M | ||
| Q2 25 | $207.7M | $78.7M | ||
| Q1 25 | $213.5M | $85.3M | ||
| Q4 24 | — | $86.2M | ||
| Q3 24 | $47.1M | $87.6M | ||
| Q2 24 | — | $90.9M | ||
| Q1 24 | — | $94.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-10.8M | $4.0M |
| 自由现金流经营现金流 - 资本支出 | $-11.0M | $3.9M |
| 自由现金流率自由现金流/营收 | -44.2% | 20.5% |
| 资本支出强度资本支出/营收 | 0.7% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.6M | — |
8季度趋势,按日历期对齐
经营现金流
CBLL
CURI
| Q4 25 | $-10.8M | $4.0M | ||
| Q3 25 | $-11.1M | $4.4M | ||
| Q2 25 | $-7.5M | $2.8M | ||
| Q1 25 | $-11.4M | $1.9M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $2.2M | ||
| Q1 24 | — | $666.0K |
自由现金流
CBLL
CURI
| Q4 25 | $-11.0M | $3.9M | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-11.6M | $1.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
CBLL
CURI
| Q4 25 | -44.2% | 20.5% | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | — | ||
| Q1 25 | -56.4% | 12.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
CBLL
CURI
| Q4 25 | 0.7% | 0.1% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 0.7% | 0.5% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率
CBLL
CURI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.56× | ||
| Q1 25 | — | 6.03× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
CURI
暂无分部数据